Articles by Susan J. Schniepp - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Susan J. Schniepp

Managing Change Control in a Changing Environment

We never thought implementing complex changes could become more cumbersome.
Feb 2, 2010

We never thought implementing complex changes could become more cumbersome.

Insider Solutions: A New Direction for USP?

With a five-yar revision cycle around the corner, USP will hit or miss the collaboration mark.
Nov 2, 2009

With a five-yar revision cycle around the corner, USP will hit or miss the collaboration mark.

Insider Solutions: Preventing the Next Heparin Scare

Determined to prevent further supply-chain breaches, industry takes charge, offers proposals.
Aug 2, 2009

Determined to prevent further supply-chain breaches, industry takes charge, offers proposals.

Insider Solutions: Device Database Can Help Pharma

Standards data is helpful, but FDA needs to apply its information across the board. This article contains bonus online-exclusive material.
Apr 2, 2009

Standards data is helpful, but FDA needs to apply its information across the board. This article contains bonus online-exclusive material.

An Analytical Technique with Special Resonance

A new book inspires readers to seek ways to apply NMR spectroscopy to their own purposes.
Feb 2, 2009

A new book inspires readers to seek ways to apply NMR spectroscopy to their own purposes.

Insider Solutions: Have a Say in USP Standards

The USP public-comment process exists for a reason. Industry needs to take advantage. This article contains bonus online-exclusive material.
Jan 2, 2009

The USP public-comment process exists for a reason. Industry needs to take advantage. This article contains bonus online-exclusive material.

Risk Management within the Global Supply Chain

The authors describe a program to identify, prioritize, mitigate, and communicate risks in manufacturer–supplier relationships.
Oct 1, 2008

The growth and globalization of the pharmaceutical supply chain make risk assessment more important than ever for pharmaceutical manufacturers. The authors describe a program to identify, prioritize, mitigate, and communicate risks in manufacturer–supplier relationships.

Help Your Contract Laboratory Help You

Providing the right information upfront may ease new requirements to assess solvent levels.
Aug 6, 2008

Providing the right information upfront may ease new requirements to assess solvent levels.

Help Your Contract Laboratory Help You

Providing the right information upfront may ease new requirements to assess solvent levels.
Jul 2, 2008

Providing the right information upfront may ease new requirements to assess solvent levels.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
6%
All of the above.
42%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here